• 제목/요약/키워드: Diabetes Mellitus type II

검색결과 90건 처리시간 0.022초

태극건강기공이 제 2형 당뇨인의 인슐린저항성 및 혈당에 미치는 효과 (The Effect of the Taeguk Gi-Gong Exercise on Insulin Resistance and Blood Glucose in Patients with Type II Diabetes Mellitus)

  • 정인숙;이화자;김명희
    • 기본간호학회지
    • /
    • 제14권1호
    • /
    • pp.44-52
    • /
    • 2007
  • Purpose: This study was done to investigate the effect of Tai Chi Qigong exercise program on insulin resistance and blood glucose in patients with type 2 diabetes. Method: This was a quasi-experimental study used a non-equivalent control group pretest-posttest design. Participants included 39 patients with type 2 diabetes mellitus patients (ages between 40-70)(experimental group, 19, control group, 20). The Tai Chi Qigong exercise program consisted of 5 minute warming up, 30-minute main exercise, and 5 minute cooling down, and was conducted twice a week for 10 weeks. The outcome variables were insulin resistance (proinsulin, C-peptide, insulin, insulin sensitivity index) and blood glucose (fasting, post prandial 2hr, HbA1c). Data was analyzed using ANCOVA, with pre-test values as covariates, to examine difference between pre and post measures between the two groups. Results: The Tai Chi Qigong was effective in lowering postprandial 2hr blood glucose. Conclusion: Twice a week 10 week-Tai Chi Qigong exercise seems to be too short to improve insulin excretion or resistance, and fasting blood sugar and HbA1C in patients with type 2 DM. A Tai Chi Qigong program at least 3 times per week or longer is recommended.

  • PDF

인슐린비의존형 노인 당뇨병환자의 엽산섭취와 혈장 호모시스테인 수준 (Folate Intakes and Plasma Homocysteine Levels in the Elderly Patients with NIDDM)

  • 장남수
    • Journal of Nutrition and Health
    • /
    • 제33권3호
    • /
    • pp.250-256
    • /
    • 2000
  • Hyperhomocysteinemia has been shown to be associated with increased risks for macrovascular angiopathy. The present study was conducted to document the relationship between plasma homocysteine levels and the presence of macrovascular angiopath in patients with Type II diabetes mellitus. Plasma total homocysteine was determined by a HPLC-fluorescence detection method in a total of 238 subjects, 127 diabetic patients and 111 control. Dietary information including folate intake was assessed by a 24-hour recall in a total 113 subjects, 70 diabetic patients and 43 control. Folate intake was significantly lower inn patients with diabetes mellitus than that in the control. The lowered folate intake in the diabetic patients was mainly due to reduced intakes of fruits and vegetables. The average plasma homocysteine level of patients with MA was 14.2$\mu$㏖/L, which was significantly higher than that of either the patients without MA(11.4$\mu$㏖/L) or the control(11.5$\mu$㏖/L). Twenty five percent of the diabetic patients were positively correlated with age (r=0.20), body weight (r=0.28), body mass index (r=0.28), body mass index (r=0.18), diastolic blood pressure (r=0.20), and total cholesterol (r=0.14). cigarette smokers had significantly higher levels of plasma homocysteine than the non-smokers. Further prospective studies are needed to investigate whether folate or other B vitamin supplementation could be beneficial for the prevention of hyperhomocysteinemia or macrovascular angiopathy in the diabetic patients.

  • PDF

12주 규칙적인 유산소 트레이닝이 제 2형 당뇨(T2DM) 환자의 간 효소(Hepatic enzyme)에 미치는 영향 (Effects of 12 Weeks Regular Aerobic Training on Hepatic Enzyme in Type 2 Diabetes Mellitus (T2DM) patients.)

  • 김영일;곽이섭
    • 생명과학회지
    • /
    • 제19권6호
    • /
    • pp.804-808
    • /
    • 2009
  • 본 연구에서는 12주 유산소 트레이닝 전에 비해 트레이닝 후, 간 기능을 나타내는 효소들이 모두 감소함을 나타냈으나 모두 통계적으로 유의한 차이는 나타내지 못했으며 이는 트레이닝이 간 기능에 영향을 미치지 못한 선행연구[5,15]들에서와 같은 결과를 나타냈다. 하지만 부분적으로 전체 대상자 13명 중 3명(23%)의 간 효소들 즉, 임상적 비정상을 나타낸 알부민(albumin), 토탈빌리루빈(total bilirubine), AST가 트레이닝 후, 정상적인 임상수치로 돌아와 규칙적인 12주 유산소 트레이닝이 제 2형 당뇨(T2DM) 환자의 간 효소에 통계적으로 유의한 차이는 나타내지 못했지만 임상적 판단 수치에 영향을 미친 것은 사실이다. 하지만 모든 비정상적인 간 기능 효소가 정상으로 회기한 것도 아니며 통계적으로 유의한 차이도 나지못했기 때문에 제 2형 당뇨환자(T2DM)의 간 기능 효소를 증진시키는 데 있어 운동 트레이닝의 효과는 성급히 판단하기 어려우며 운동 강도와 기간 등 좀 더 세분화고 다양한 연구가 필요하다고 생각된다.

당뇨 모델쥐의 간관 췌장에서 타우린이 지질과산화물 생성과 글루타티온 의존성 효소의 활성에 미치는 영향 (Effect of Taurine Supplement on the Lipid Peroxide Formation and the Activity of Glutathione-Dependent Enzyme in the Liver and Islet of Diabetic Model Mice)

  • 임은영;김해리
    • 한국식품영양과학회지
    • /
    • 제24권2호
    • /
    • pp.195-201
    • /
    • 1995
  • 당뇨 모델에서 타우린의 보강에 의한 지질과산화물의 생성과 GSH 관련 효소들의 활성에 미치는 영향을 알아보고자 alioxan을 이용한 I형과 KK-mouse에 고열량식이를 이용하여 II형 당뇨를 유도하였다. I형과 II형 각각에 정상대조군, 타우린보강군, 당뇨군, 타우린보강 당뇨군을 두어, 모두 8개 군으로 나누었으며, 타우린의 보강은 7일 동안 5%(w/v) 수준으로 자유로이 마시게 하였다. 간과 췌장에서 malondialdehycel(MDA), gluta-thione peroxidase(GPX), glutathions S-transferase(GST)의 활성을 측정하였다. 간조직에서 지질과산화물의 함량은 I형의 경우 당뇨군에서 매우 증가했고 타우린 보강에 의한 유의적으로 감소한 것을 볼 수 있었으며, II형에서는 타우린보강에 의해 유의적인 차이가 없었다. 췌장도 간과 같은 결과를 나타내었다. GPX의 활성은 간에서 I형 당뇨군이 유의적으로 증가했으나, II형 당뇨군에서는 유의적으로 감소했다. 타우린의 보강에 의해 GPX활성에는 유의적인 차이가 없었으며 췌장에서도 간과 비슷한 결과를 보였다. GST의 경우에도 당뇨 유도에 의한 활성 변화는 있었으나 타우린의 보강에 의한 활성 변화는 보이지 않았다. 이상의 결과들로 미루어 당뇨에 있어 타우린의 항산화작용은 당뇨 모델의 종류에 따라 다르며, GSH 관련 효소들의 활성변화 보다는 I형 당뇨 모델의 간과 췌장에서 지질과산화물의 생성을 억제하는 작용을 하리라고 생각 된다.

  • PDF

제 2형 당뇨병 환자에서 사상체질에 따른 경구 혈당강하요법의 치료 반응성 및 사용 패턴 평가 (The Difference of Efficacy for Oral Hypoglysemic Pharmacotherapy Based on Sasang Constitutional Medicine Among Type II Diabetes Mellitus Patients in Korea)

  • 김지연;이명구;김정태;임성실
    • 약학회지
    • /
    • 제58권1호
    • /
    • pp.71-79
    • /
    • 2014
  • Although Korean patients with type 2 diabetes mellitus (T2DM) are generally treated by western medicine, many of them strongly believe in the traditional oriental Sasang constitutional classification and depend on it for food, health supplements, and oriental medicines decision making. Sasang constitutional classification is a part of traditional Korean medicine that divides people into four constitutional types (Tae-Yang: TY, Tae-Eum: TE, So-Yang: SY, and So-Eum: SE), which differ in inherited characteristics such as appearance, personality traits, susceptibility to diseases, and drug responses. It is recommended for T2DM patients to control their blood glucose very well from early stages with drugs and diet. However, many T2DM patients respond differently to their drugs, even though they receive the same medicine. Therefore, the present study investigated whether Sasang constitutional type can explain the therapeutic differences between oral hypoglycemic agents (OHAs) therapy (mono, dual and triple drug therapy). Patients of 618 with T2DM diagnosis and Sasang constitutional type known who received both western and oriental medicine treatment in a hospital between April 2006 and April 2013 retrospectively studied. HbA1c (%) and blood glucose (mg/dl) levels before OHAs therapy and 3 month after were collected for metformin (MET) or sulfonylurea (SU) monotherapy, MET+SU dual therapy, MET+except SU (where was either alpha-glucosidase inhibitor, dipeptidyl peptidase-4 inhibitor, meglitinide or thiazolidinedione) dual therapy, and triple therapy, according to Sasang constitutional type. For statistical analysis, ANOVA was used and paired t-test by SPSS 19.0 where P values less than 0.05 were considered statistically significant. Pattern was similar levels of HbA1c and blood glucose and which was decreased in order of mono, MET+SU dual, MET+except SU dual and triple therapy. In all patients comparison, for the So-yang (SY) constitutional type, either monotherapy was less effective; for Te-eum (TE) type, MET+SU dual therapy was less effective while MET+except SU dual therapy was more effective and the triple therapy was less effective; and for So-eum (SE) type, the triple therapy was more effective. For the management of TE type it is recommended to use drugs except SU when dual therapy is needed, restrict triple therapy and consider dual and insulin therapy; for SY type it is recommended to follow current guidelines; and for SE type it is advisable to skip dual therapy and start the triple therapy early. Finally, the therapeutic response to OHAs is different among Korean T2DM patients with different Sasang constitutional types. Taken together, the choice of effective OHAs therapy for each type is necessary in order to minimize the poor control of blood glucose level, the risk of complications, and the costs from a failure of therapy.

Guar gum이 type-II 당뇨병 환자의 혈액성분에 미치는 영향 (Effect of guar gum on the blood composition in type-II diabetic subjects)

  • 김은미
    • Journal of Nutrition and Health
    • /
    • 제22권6호
    • /
    • pp.457-465
    • /
    • 1989
  • Guar gum, a storage polysaccharide galactomannan was administered to 11 patients with type-II diabetes mellitus for 7 days and 3 weeks. They took 5 grams of guar gum 30 mins before each of three meals daily. The dinner 2-h postprandial values of their blood glucose were significantly lowered (P<0.05) after their guar treatment for 7 days compared with before taking guar gum. The 2-h postprandial values of blood glucose were significantly lowered(P<0.05) after 3 weeks of gual treatment compared with before taking guar gum. In an oral glucose tolerance test, their blood glucose values were significantly lowered at 120 mins(P<0.02) and 180 mins(P<0.05) after guar treatment. Total-lipid(P<0.01) and triglycerides(P<0.02) of their blood were significantly decreased and HDL-cholesterol(P<0.02) was significantly increased after guar treatment. HbA1C was significantly reduced (P<0.05) from 11.3% to 10.1% The body weight, total-cholesterol and insulin activity of the patients after guar treatment were not significantly changed and the satiety ratings of the patients with guar treatment was not significantly changed and the satiety ratings of the patients with guar treatment was not significantly changed, however, the subjects that answered from 'Want to eat but can wait' to 'No desire to eat' were 81.1%. It is concluded that guar gum improves their carbohydrate and lipid metabolism in Korean type-II diabetic subjects with high fiber diets.

  • PDF

Generation of Transgenic Mice Overexpression Mouse RESISTIN

  • J. R. Chun;S. J. Song;J. T. Do;K. S. Chung;Lee, H. T.
    • 한국수정란이식학회:학술대회논문집
    • /
    • 한국수정란이식학회 2002년도 국제심포지엄
    • /
    • pp.99-99
    • /
    • 2002
  • The hormone resistin is associated with typeII diabetes mellitus in rodent model. Resistin impairs glucose tolerance and insulin action. A new class of anti-diabetic drugs were called thiazolidinediones (TZDs) downregulates a resistin which is induced during adipocyte differentiation. But the connection between increased adiposity and resistin remains unknown. The objectives of this study was to clone a mouse resistin cDNA and to generate transgenic mice overexpressing mouse resistin gene. The 555 bp of mouse resistin was amplified from mob cDNAS by polymerase chain reaction (PCR) and cloned into pCR$\^$(R)/ 2.1 TOPO T-vector. Mouse resistin mRNA on the basis of Genbank sequence (acession no. AF323080). Then, the PCR product was cloned into pTargeT$\^$TM/ mammalian expression vector that has pCMV promoter and chimeric intron. Restriction enzyme analysis with BamH I and Not I was carried out to determine an orientation of the insert in the vector. The pCMV-mus/resistin gene was prepared from previous recombinant pTargeT$\^$TM/-mus/resistin by digestion of Bgl II, and has used for microinjection into pronuclei of one cell embryos. The microinjected embryos were transfered to pseudopregnant foster-mother. Mouse resistin expression was detected in transgenic F1 mice by Reverse Transcriptase- Polymerase Chain Reaction (RT-PCR). Resistin gene expression mouse has heavier body weight which was measured higher level of plasma glucose than that of normal mouse. And in diet-induced experiments, the abdominal fat pads were isolated from each 24h starvation and re-feeding after fasting group mice that were assessed by RT-PCR analysis. In fasting group mice, resistin expression was higher than that of re-feeding group mice. This result suggests that the resistin gene overexpressing mice may be became to obesity and be useful as an animal disease model to be diabetes mellitus caused by insulin resistance of resistin.

  • PDF

제 2형 당뇨환자의 우울증상군과 비우울증상군 간의 당화혈색소, 자가 관리, 삶의 질 간의 비교연구 (Comparative Study on HbA1C, Self-care Behavior, and Quality of Life by Depression Status in Type II Diabetic Patients)

  • 정영민;김미영
    • 기본간호학회지
    • /
    • 제19권3호
    • /
    • pp.353-362
    • /
    • 2012
  • Purpose: The objective of this study was to examine the correlation between HbA1C, self-care behavior, and quality of life among depressed and non-depressed patients with type II diabetes Methods: Data were collected between May 26 and July 5, 2011 using a questionnaire. The questionnaire included depression (CES-D), self-care behavior and quality of life. Hemoglobin A1C was ed from medical records. Data were analyzed by descriptive statistics, t-test, $x^2$-test, ANCOVA and Pearson's correlation coefficient. Results: In this study sample (n=301), 20.9% of diabetic patients (n=69) were depressed. After adjustment for relevant covariates, depressed patients showed to have lower self-care behavior (2.8 vs 3.4, p<.001) and quality of life (2.8 vs 3.5, p<.001) scores, but the difference in HbA1C was no longer significant. Conclusion: This study suggests that the assessment and intervention for depressed diabetic patients can result in effective self-care behavior, which accordingly leads to improvement of the quality of life.